Evidence map›Paper›PMID 39895429›Full record

ArticlePediatric blood & cancer2025

Hydroxyurea Therapy and Sleep-Disordered Breathing in Children With Sickle Cell Disease.

Zachary Abramson, Ayobami Olanrewaju, Guolian Kang, Yunusa Olufadi, Pei-Lin Chen, Parul Rai, Andrew M Heitzer, Clifford M Takemoto, Ahsan Bashir, Nour Akil and 1 more

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zachary AbramsonDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0001-7875-1187
Ayobami OlanrewajuDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Guolian KangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Yunusa OlufadiDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pei-Lin ChenLongitudinal Clinical Cohort of Sickle Cell Clinical Research and Intervention Program, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Parul RaiDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Andrew M HeitzerDepartment of Psychology and Behavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Clifford M TakemotoDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0002-2832-6884
Ahsan BashirDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Nour AkilDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jane S HankinsDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0003-4439-7321

Funding

School Readiness Intervention for Preschool Children with Sickle Cell DiseaseK23HL166697 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Andrew M Heitzer · 2023 to 2026
$648k
NHLBI NIH HHS K23 HL166697NHLBI NIH HHS L40 HL165511NIH loan repayment program award 1L40HL165511-01
6 · The paper itself

Abstract

Bidirectional relationships exist among sickle cell disease (SCD), sleep-disordered breathing (SDB), and hydroxyurea therapy, and this complex interplay poses challenges to research attempting to elucidate causal mechanisms and determine therapeutic targets. We therefore set out to study all three components of this clinical triad simultaneously (SCD, SDB, and hydroxyurea therapy), documenting correlations and suggesting underlying pathophysiological mechanisms. Hydroxyurea therapy was associated with improved SDB and with decreased inflammation, implicating the anti-inflammation effects of hydroxyurea as a plausible mechanism driving these correlations. These results underscore the need for longitudinal studies to elucidate causal relationships.

Indexed as

Anemia, Sickle CellAntisickling AgentsHydroxyureaSleep Apnea SyndromesAdolescentChildChild, PreschoolFemaleHumansMaleAntisickling AgentsHydroxyureahydroxyureasickle cell anemiasleep apneasleep‐disordered breathing

Identifiers

PMID39895429
PMCPMC12869370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.